Organon OGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $146M— | —— | $160M+10.3% | $145M+66.7% | $87M-20.2% | ||
| $39M-15.2% | $46M+15.0% | $40M+11.1% | $36M+5.9% | $34M0.0% | ||
| $19M+171% | $7M-70.8% | $24M+9.1% | $22M-8.3% | $24M-7.7% | ||
| $3M-90.0% | $30M-25.0% | $40M+300% | $10M+159% | -$17M— | ||
| $81M— | —— | —— | —— | $0— | ||
| $65M+141% | -$160M-3,300% | $5M+156% | -$9M-111% | $85M+125% | ||
| $9M— | —— | $63M+85.3% | $34M+1,233% | -$3M-110% | ||
| $32M+127% | -$120M— | —— | —— | -$149M— | ||
| $95M+161% | -$156M-314% | $73M+174% | -$98M-351% | $39M+153% | ||
| -$8M+20.0% | -$10M-25.0% | -$8M+90.1% | -$81M-102% | -$40M— | ||
| -$4M+87.1% | -$31M+59.2% | -$76M-1,050% | $8M-78.9% | $38M+143% | ||
| $15M— | —— | —— | $67M+509% | $11M-80.4% | ||
| $5M-87.8% | $41M+28.1% | $32M+367% | -$12M-9.1% | -$11M0.0% | ||
| $225M+59.6% | $141M-46.6% | $264M+20.0% | $220M+193% | $75M-80.8% | ||
| $37M-17.8% | $45M-2.2% | $46M+17.9% | $39M+21.9% | $32M-41.8% | ||
| $0— | —— | —— | —— | $75M-54.8% | ||
| $433M— | —— | —— | —— | $0— | ||
| $0— | —— | $69M— | —— | $55M+71.9% | ||
| $10M-50.0% | $20M— | —— | —— | $10M-77.8% | ||
| $386M+694% | -$65M+43.5% | -$115M-203% | -$38M+77.9% | -$172M+41.9% | ||
| $5M+25.0% | $4M+33.3% | $3M-70.0% | $10M-85.9% | $71M-4.1% | ||
| $0-100% | $325M+8.3% | $300M-11.8% | $340M+278% | $90M-40.0% | ||
| $32M-93.7% | $507M+36.3% | $372M-31.2% | $541M+482% | $93M-38.8% | ||
| $1M0.0% | $1M0.0% | $1M-91.7% | $12M+1,100% | $1M-75.0% | ||
| -$38M+79.7% | -$187M-146% | -$76M+65.9% | -$223M-197% | -$75M+8.5% | ||
| -$31M-338% | $13M— | $0-100% | $93M+111% | $44M+144% | ||
| $542M+653% | -$98M— | —— | —— | -$128M-45.5% | ||
| $47M-6.0% | $50M-3.8% | $52M-1.9% | $53M+6.0% | $50M+16.3% | ||
| $5M-87.8% | $41M+28.1% | $32M+367% | -$12M-9.1% | -$11M0.0% | ||
| $39M-15.2% | $46M+15.0% | $40M+11.1% | $36M+5.9% | $34M0.0% | ||
| -$3M-123% | $13M+44.4% | $9M+156% | -$16M-207% | $15M— | ||
| $81M— | —— | —— | —— | $0— | ||
| $32M+127% | -$120M— | —— | —— | -$149M— | ||
| $15M— | —— | —— | $67M+509% | $11M-80.4% | ||
| —— | $2.25M0.0% | $2.25M0.0% | $2.25M0.0% | $2.25M— | ||
| -$12M+55.6% | -$27M-68.8% | -$16M+33.3% | -$24M-20.0% | -$20M+13.0% | ||
| $0— | $0— | $0— | $0-100% | $6M— | ||
| $0— | —— | —— | —— | $75M-54.8% | ||
| $10M-50.0% | $20M— | —— | —— | $10M-77.8% | ||
| $0— | —— | $69M— | —— | $55M+71.9% | ||
| $188M+95.8% | $96M-56.0% | $218M+20.4% | $181M+321% | $43M-87.2% | ||
| $188M+95.8% | $96M-56.0% | $218M+20.4% | $181M+321% | $43M-87.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Organon's cash flow data come from?
- Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.